Literature DB >> 12718636

Study of Prevention of Colorectal Cancer through Lifestyle Modification: an Introduction to the Protocol.

Tatsuya Ioka1, Hideki Ishikawa, Ikuko Akedo, Tomiyo Nakamura, Ikuko Takeyama, Sachiyo Otani, Takaichiro Suzuki, Itaru Kaji, Yoshihiko Naito, Minoru Iida, Kanehisa Morimoto, Toru Otani.   

Abstract

Previous epidemiological studies have suggested that lack of exercise and a high fat diet increase the risk of colorectal cancer. We planned a clinical trial to test these propositions, using subjects with multiple colorectal adenomas and/or carcinomas. Enrolment in this study was conducted in two stages. First, patients were invited to participate in the dietary modification part of the study. Those agreeing to participate were given dietary advice, and 3 months later all subjects to whom the exercise exclusion criteria do not apply were invited to participate in the exercise part of the study. The subjects were randomized to two groups. A total of two hundred and eleven patients meeting the entry criteria have been invited to join the trial, of whom 165 (78%) consented to participate in the dietary modification part of the study. After excluding those unsuitable according to the exclusion criteria for the exercise regimen, the remaining 124 subjects were further invited to participate in the exercise regimen part of the study. One hundred and three (83%) subjects have given their consent. Obtaining informed consent in two stages and the free provision of lifestyle modification measures were factors that contributed to this favorable participation rate.

Entities:  

Year:  2001        PMID: 12718636

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  1 in total

1.  Effect of physical fitness on colorectal tumor development in patients with familial adenomatous polyposis.

Authors:  Tomiyo Nakamura; Hideki Ishikawa; Toshiyuki Sakai; Makoto Ayabe; Keiji Wakabayashi; Michihiro Mutoh; Nariaki Matsuura
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.